Edwards Lifesciences Q2 EPS $0.66 Beats $0.65 Estimate, Sales $1.53B Beat $1.50B Estimate
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences (NYSE:EW) reported Q2 earnings of $0.66 per share, beating the analyst consensus estimate of $0.65 by 1.54%. The company also reported quarterly sales of $1.53 billion, beating the analyst consensus estimate of $1.50 billion by 2.00%. This represents a 4.76% increase in earnings and an 11.35% increase in sales compared to the same period last year.
July 26, 2023 | 8:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences reported better than expected Q2 earnings and sales, which could positively impact its stock price in the short term.
Edwards Lifesciences reported higher than expected earnings and sales for Q2. This positive financial performance could increase investor confidence and demand for the stock, potentially driving its price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100